Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50014647
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578391(CHEMBL4864129)
Affinity DataIC50: 0.290nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578388(CHEMBL4858144)
Affinity DataIC50: 0.300nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578395(CHEMBL4873266)
Affinity DataIC50: 0.520nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578387(CHEMBL4870159)
Affinity DataIC50: 0.570nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578393(CHEMBL4855908)
Affinity DataIC50: 0.740nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578389(CHEMBL4862010)
Affinity DataIC50: 1.60nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578391(CHEMBL4864129)
Affinity DataIC50: 4.10nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578394(CHEMBL4876056)
Affinity DataIC50: 5.70nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578387(CHEMBL4870159)
Affinity DataIC50: 7nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578390(CHEMBL4867286)
Affinity DataIC50: 7.70nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578396(CHEMBL4876080)
Affinity DataIC50: 8.70nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578395(CHEMBL4873266)
Affinity DataIC50: 8.70nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578388(CHEMBL4858144)
Affinity DataIC50: 9nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578389(CHEMBL4862010)
Affinity DataIC50: 9.10nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578396(CHEMBL4876080)
Affinity DataIC50: 24nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578390(CHEMBL4867286)
Affinity DataIC50: 62nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2a(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578392(CHEMBL4865474)
Affinity DataIC50: 84nMAssay Description:Antagonist activity at human A2aR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578392(CHEMBL4865474)
Affinity DataIC50: 91nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578394(CHEMBL4876056)
Affinity DataIC50: 128nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetAdenosine receptor A2b(Human)
Therachem Research Medilab

Curated by ChEMBL
LigandPNGBDBM50578393(CHEMBL4855908)
Affinity DataIC50: 282nMAssay Description:Antagonist activity at human A2bR expressed in CHO-K1 cells assessed as inhibition of cAMP accumulation preincubated for 30 mins followed by adenosin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed